FierceBiotech’s 2011 “Fierce 15” Winners to be Showcased at BioPharm America™
FierceBiotech, the biotech industry’s daily monitor, today announced that its 2011 “Fierce 15” winners will be showcased at BioPharm America™, being held at the Westin Boston Waterfront Hotel on September 7–9. The Fierce 15 is the hotly anticipated annual award that recognizes the 15 most promising private biotech companies in the world.
“Having FierceBiotech recognize the 2011 ‘Fierce 15’ winners at BioPharm America is a great addition to this year’s program,” said Carola Schropp, President of EBD Group, organizers of the conference. “Fierce 15 companies represent some of the most exciting ‘partnerable’ companies in the industry, and profiling these companies at BioPharm America—one of largest and most productive dealmaking events of the year—is a natural fit.”
An internationally recognized daily newsletter reaching more than 90,000 biotech and pharma industry professionals, FierceBiotech provides subscribers with a quick authoritative briefing on the day's top stories, with a special focus on drug discovery and clinical trials.
“Writing the Fierce 15 is the most fun I have all year," said John Carroll, FierceBiotech’s Editor-in-Chief, who worked on this year’s report with Executive Editor Ryan McBride. "It’s a chance to showcase some of the most talented and creative drug developers in the industry. They might not all make it, but they won’t fail for lack of trying. They are the smartest, gutsiest companies I’ve ever profiled. And each of this year's winners offers us a lesson on what it takes to create success in the drug development field."
Carroll will also introduce a few of the Fierce 15 CEOs during the “Fierce 15 Revealed” session and discuss what it currently takes to attract venture backing and top partners in a tough financing environment.
BioPharm America annually hosts top dealmakers from around the world seeking to do business with innovative companies and organizations. The "Fierce 15" celebrates the spirit of being "fierce," championing innovation and creativity, even in the face of intense competition.
“We at MassBio watch the ‘Fierce 15’ each year with great interest, and are always excited to see strong Massachusetts representation on the list,” said Robert K. Coughlin, President and CEO of MassBio. “Showcasing the 2011 ‘Fierce 15’ at BioPharm America—the premier partnering conference on the East Coast—really drives home the meaning of this event, to connect with many people and collaborate with the right people to move innovation forward.”
BioPharm America is produced by EBD Group in collaboration with MassBio. For more information, go to: http://www.ebdgroup.com/bpa.